BRUSSELS (Reuters) – European Union industry commissioner Thierry Breton said on Wednesday the COVID-19 vaccine production capacity of a factory in Belgium that produced shots for AstraZeneca had “drastically” increased.
The factory, now owned by U.S. firm Thermo Fisher, had been seen as the main cause of a large cut in supplies by the Anglo-Swedish firm to the EU in the first quarter of this year.
(Reporting by Francesco Guarascio @fraguarascio; Editing by Jon Boyle)
